Grants Mobilize Pursuit of All Possible Paths to a Cure
NEW YORK,
The Parkinson's Disease Foundation® (PDF®), a division of the
Parkinson's Foundation, seeks research proposals for emerging ideas to help
solve, treat and end the disease. PDF investments of $2.7 million are
part of its comprehensive strategy to mobilize the pursuit of all possible
paths to a cure. Scientists can apply by visiting grants.pdf.org.
"Over the past 10 years, scientific
progress in Parkinson's may have been difficult to see, as only a handful of
new drugs were approved. But behind the scenes, thanks to PDF's
commitment to basic science, we have more potential drug targets than we had 10
years ago. Some of them may one day slow or stop the disease in its
tracks," said James Beck, Ph.D., Vice President, Scientific Affairs,
PDF. "To get there, we need to pick up the pace – to mobilize
researchers to pursue every promising idea to improve lives and end the disease
forever."
It is estimated that the number of people
living with Parkinson's will double by 2030. While research is promising,
no therapy has been proven to slow or stop the disease. To meet the needs
of its growing community, PDF grant opportunities reflect a continued
commitment to basic science to keep the therapy pipeline full and identify
possible cures, and increased investments for cutting-edge clinical research to
solve unmet needs in Parkinson's disease.
"For people like me who live with
Parkinson's, every day matters," said Ron Wincek, Ed.S., a PDF Research
Advocate of Atlanta, GA. "In working alongside PDF and its expert
scientists, I learned that it matters to them too. I am hopeful that
together, we can end this disease."
PDF grant opportunities are listed below.
These include opportunities for basic and clinical scientists and
multidisciplinary teams, including those with expertise in the field and those
who bring fresh perspectives to PDF's goal of ending Parkinson's.
Career Development Awards
• Stanley
Fahn Junior Faculty Award: awards of $300,000 available (over three years) for junior
faculty members. Letter of intent due Sunday, November 27, 2016.
PDF Fellowships
• Postdoctoral Fellowships for Basic Scientists: awards of $100,000 available (over two
years) for early-career scientists, within five years of their Ph.D. training,
to study promising ideas in Parkinson's disease at major research institutions.
Letter of intent due Sunday, November 27, 2016.
• Postdoctoral Fellowships for Clinical Neurologists: awards of $120,000 available (over two
years) for young clinicians who have completed their neurology residency within
the past three years, to pursue clinical research projects in Parkinson's
disease. Letter of intent due Sunday, November 27, 2016.
Advancing Parkinson's Therapies Grants
• Conference Awards: awards of $10,000 to $15,000 available to independent
investigators looking to explore unsolved clinical or basic science problems in
Parkinson's disease through collaborative conferences with research, health and
patient leaders, in and outside of the Parkinson's disease field.
Applications are rolling and are accepted year-round.
• PAIR Leadership
Awards: awards of $5,000 to
$10,000 available to support teams of scientists and patient advocates (people
with Parkinson's and care partners) who are leading the field in developing
collaborative models for conducting Parkinson's disease research. Applications
are accepted year-round.
• Translational Research Grants (an extension of the Community Choice
Research Awards Program): $500,000 available (capped at $100,000 per
award) for clinical, pre-clinical or basic research proposals that will
directly impact our understanding of four target symptomatic areas in
Parkinson's — cognitive change, dystonia, fatigue and gastrointestinal
dysfunction. Applications closed. Reviews ongoing.
Collaborative Fellowships
• PDF-PSG Mentored
Clinical Research Award: award of $50,000 available (for one year) for one investigator
with potential to become an independent investigator to conduct a project in
patient-oriented research in Parkinson's under the mentorship of an experienced
investigator in the field. Applications due Friday, January 6, 2017. Offered in collaboration with the Parkinson Study Group (PSG).
• PDF-HHMI Medical
Fellows Initiative: award of $43,000
available (for one year) for one medical student to immerse him or herself in
full-time basic, translational or applied biomedical Parkinson's disease
research under the mentorship of an experienced investigator in the field.
Offered in collaboration with the Howard Hughes Medical Institute (HHMI).
Applications due Wednesday, January 11, 2017.
• PDF-APDA Summer Student Fellowships: awards of $4,000 available (for 10 weeks)
for advanced undergraduates and medical students to pursue Parkinson's-related
research projects and gain the tools they need to transition into future
leaders. Each awardee is eligible to apply for up to $1,000 for travel to
present their Parkinson's project data at a related conference. Jointly
sponsored with the American Parkinson Disease Association (APDA). Applications
due Monday, January 23, 2017.
• PDF-AAN/ABF Fellowship: award of $130,000 available (for two years) for one
investigator who has completed a residency or a postdoctoral fellowship to
train as a clinician-scientist in the field of Parkinson's under the mentorship
of an experienced investigator in the field. Offered in collaboration
with the American Brain Foundation, a foundation of the American Academy of
Neurology. Applications closed. Reviews ongoing.
Grant applications are peer-reviewed by
leading clinical and basic scientists in Parkinson's and, in line with PDF's
commitment to patient
engagement in research, by people who are living with Parkinson's.
For more information on these grant opportunities, contact PDF at (212)
923-4700 or grants@pdf.org or visit grants.pdf.org.
About Parkinson's Disease (PD)
Parkinson's disease is a progressive
neurological disorder that affects nearly one million people in the US and over
10 million worldwide. Parkinson's is the second most common
neurodegenerative disease after Alzheimer's and is the 14th leading cause of
death in the US. It is associated with a loss of motor control (e.g.,
shaking or tremor at rest and lack of facial expression) as well as non-motor
symptoms (e.g., depression and anxiety). Although promising research is
being conducted, there is currently no cure for Parkinson's disease.
About Research Leadership at PDF
As part of the Parkinson's Disease
Foundation® (PDF®) strategy to end Parkinson's, PDF mobilizes
leaders in the research community to help us more quickly solve, treat and end
the disease. To date, PDF has invested $115 million in Parkinson's
research, which has advanced our understanding of the disease, improved
millions of lives worldwide and paved the way for a strong therapeutic pipeline
that is likely to meet the needs of the community. PDF investments play
an integral role in driving interdisciplinary research, advancing the careers
of next-generation research leaders, shaping patient-centric research and
disseminating scientific information throughout the research, health and
patient communities, via our journal dedicated to understanding Parkinson's
disease, npj Parkinson's
Disease. PDF research
investments are listed on the PDF website at www.pdf.org/results_funded.
About the Parkinson's Disease Foundation, a division of the
Parkinson's Foundation
The
Parkinson's Foundation is working toward a world without Parkinson's disease.
Formed by the merger of National Parkinson Foundation (NPF) and the
Parkinson's Disease Foundation (PDF) in August 2016, the mission of the
Parkinson's Foundation is to invest in promising scientific research that will
end Parkinson's disease and improve the lives of people with Parkinson's and
their families, through improved treatments, support and the best care.
For more information, visit www.pdf.org
or www.parkinson.org or call (800) 457-6676
or (800) 4PD-INFO (473-4636).
SOURCE Parkinson's Disease Foundation
Related Links
http://www.prnewswire.com/news-releases/parkinsons-disease-foundation-opens-27-million-in-research-funding-to-solve-treat-and-end-parkinsons-300354112.html?
My husband was diagnosed with early onset Parkinson's disease at 57.his symptoms were shuffling of feet,slurred speech, low volume speech, degradation of hand writing, horrible driving skills, right arm held at 45 degree angle, things were tough for me, but now he finally free from the disease with the help of total cure ultimate health home, he now walks properly and all symptoms has reversed, he had trouble with balance especially at night, getting into the shower and exiting it is difficult,getting into bed is also another thing he finds impossible.we had to find a better solution for his condition which has really helped him a lot,the biggest helped we had was ultimatehealthhome they walked us through the proper steps,am highly recommended this ultimatehealthhome@gmail.com to anyone who needs help.
ReplyDelete